FindTrial
Sign In

Effect of Tizanidine on the Reflex in the Upper Extremity

Effect of Tizanidine on the Reflex in the Upper Extremity - Tizanidine and reflex properties

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON30170
Enrollment
5
Registered
2006-08-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spasticity

Interventions

One single dose of 4 mg tizanidine orally administered.

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: healthy, age 40-65 years

Exclusion criteria

Exclusion criteria: liver disease or malfunction, use of medication, pain on moving of the wrist, limited movement of the wrist

Design outcomes

Primary

MeasureTime frame
Outcome variable: gain for the velocity component of reflexes.—

Secondary

MeasureTime frame
Outcome parameters: total joint impedance, reflex impedance, EMG amplitude and duration of reflex activity, reaction time.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)